Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis

Published:2010 Issue:3 Volume:12 Page:R107
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

McCann Fiona E,Palfreeman Andrew C,Andrews Melanie,Perocheau Dany P,Inglis Julia J,Schafer Peter,Feldmann Marc,Williams Richard O,Brennan Fionula M

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA-approved PDE4 inhibitors alleviate the dominant toxicity of ALS–FTD-associated CHCHD10S59L by reducing the PINK1/Parkin pathway;2024-09-10

2. Phosphodiesterase-4-Inhibitoren in der Dermatologie;Die Dermatologie;2024-08-30

3. PDE4 inhibitors: potential protective effects in inflammation and vascular diseases;Frontiers in Pharmacology;2024-06-10

4. FDA-approved PDE4 inhibitors reduce the dominant toxicity of ALS–FTD-associatedCHCHD10^S59L;2024-06-06

5. The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritis;Nature Communications;2024-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP